Get the Stockscreener App
1.19
4.80%
-0.06
Revelation Biosciences Inc stock is traded at $1.19, with a volume of 72,523.
It is down -4.80% in the last 24 hours and down -20.67% over the past month.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
See More
Previous Close:
$1.25
Open:
$1.23
24h Volume:
72,523
Relative Volume:
0.19
Market Cap:
$2.76M
Revenue:
-
Net Income/Loss:
$-15.52M
P/E Ratio:
-0.064
EPS:
-18.58
Net Cash Flow:
$-16.61M
1W Performance:
-7.75%
1M Performance:
-20.67%
6M Performance:
-58.39%
1Y Performance:
-90.96%
1-Day Range:
$1.17
$1.25
1-Week Range:
$1.17
$1.38
52-Week Range:
$0.702
$20.16
Revelation Biosciences Inc Stock (REVB) Company Profile
Name
Revelation Biosciences Inc
Sector
Industry
Phone
650-800-3717
Address
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
Compare REVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
REVB
Revelation Biosciences Inc
|
1.18 | 2.92M | 0 | -15.52M | -16.61M | -18.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.52 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.42 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.79 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.21 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.05 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Revelation Biosciences Inc Stock (REVB) Latest News
Tick level data insight on Revelation Biosciences Inc. Equity Warrant volatilityJuly 2025 Catalysts & Weekly Momentum Picks - newser.com
Volume spikes in Revelation Biosciences Inc. stock – what they mean2025 Stock Rankings & Real-Time Chart Breakout Alerts - newser.com
Pattern recognition hints at Revelation Biosciences Inc. Equity Warrant upside2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com
Will Revelation Biosciences Inc. Equity Warrant stock benefit from AI adoptionJuly 2025 Final Week & Real-Time Stock Price Movement Reports - newser.com
Why Revelation Biosciences Inc. stock could outperform in 2025Earnings Recap Summary & AI Enhanced Trading Alerts - newser.com
Can Revelation Biosciences Inc. stock continue upward trendEarnings Trend Report & Weekly Stock Breakout Alerts - newser.com
What catalysts could drive Revelation Biosciences Inc. Equity Warrant stock higherSwing Trade & Fast Gain Stock Tips - newser.com
Will Revelation Biosciences Inc. Equity Warrant stock outperform Dow Jones indexEarnings Overview Report & Advanced Swing Trade Entry Plans - newser.com
Does Revelation Biosciences Inc. Equity Warrant stock trade at a discount to peersBull Run & Technical Confirmation Trade Alerts - newser.com
Is Revelation Biosciences Inc. stock attractive for growth ETFsTrade Risk Summary & Weekly Top Gainers Trade List - newser.com
Chart based analysis of Revelation Biosciences Inc. Equity Warrant trends2025 Buyback Activity & Weekly Stock Breakout Alerts - newser.com
Using Bollinger Bands to evaluate Revelation Biosciences Inc. Equity Warrant2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
Will Revelation Biosciences Inc. stock pay special dividendsTrade Risk Report & Safe Entry Trade Signal Reports - newser.com
How institutional buying supports Revelation Biosciences Inc. Equity Warrant stockJuly 2025 EndofMonth & Risk Controlled Stock Alerts - newser.com
Can Revelation Biosciences Inc. Equity Warrant stock sustain institutional interestMarket Activity Recap & Verified Swing Trading Watchlists - newser.com
Using data filters to optimize entry into Revelation Biosciences Inc.Rate Hike & Weekly Watchlist of Top Performers - newser.com
Advanced analytics toolkit walkthrough for Revelation Biosciences Inc. Equity WarrantMarket Volume Report & Expert Curated Trade Setup Alerts - newser.com
How high can Revelation Biosciences Inc. Equity Warrant stock goEarnings Recap Report & Entry Point Confirmation Alerts - newser.com
Analyzing recovery setups for Revelation Biosciences Inc. Equity Warrant investorsPortfolio Risk Report & Intraday High Probability Alerts - newser.com
Published on: 2025-11-02 03:27:05 - newser.com
Best data tools to analyze Revelation Biosciences Inc. Equity Warrant stockWeekly Earnings Recap & Weekly Return Optimization Alerts - newser.com
Why Revelation Biosciences Inc. Equity Warrant stock could rally in 2025Weekly Trade Analysis & Verified Momentum Stock Alerts - newser.com
Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date - El Paso Times
Will Revelation Biosciences Inc. stock benefit from automation2025 Pullback Review & Advanced Technical Analysis Signals - newser.com
How Revelation Biosciences Inc. Equity Warrant stock reacts to oil pricesJuly 2025 Highlights & Consistent Growth Equity Picks - newser.com
REVB Form 4: Director awarded 15,625-share grant at $1.28 - Stock Titan
[Form 4] REVELATION BIOSCIENCES, INC. Insider Trading Activity - Stock Titan
Revelation Biosciences director awarded 15,625 shares; vest Jan 2026 - Stock Titan
REVB CFO awarded 390,614 RS under 2021 plan, vests over 1 year - Stock Titan
REVB Form 4: 15,625 restricted shares vesting Jan 28, 2026 - Stock Titan
Revelation Biosciences announces cancellation of Special Meeting - MSN
Applying Elliott Wave Theory to Revelation Biosciences Inc.2025 Performance Recap & Community Trade Idea Sharing - newser.com
Best data tools to analyze Revelation Biosciences Inc. stockTrade Entry Report & AI Forecasted Stock Moves - newser.com
Analyzing Revelation Biosciences Inc. with multi timeframe chartsExit Point & AI Enhanced Trading Alerts - newser.com
What to do if you’re stuck in Revelation Biosciences Inc. Equity Warrant2025 Technical Patterns & Free Community Consensus Stock Picks - newser.com
Revelation Biosciences Inc Stock (REVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):